Mutational Landscape of HER2-low Breast Carcinoma

被引：0
|
作者：
Lukose, Georgi [1 ]
Munoz-Zuluaga, Carlos [1 ]
Munoz-Arcos, Laura [2 ]
Michaud, Olivier [2 ]
Cristofanilli, Massimo [1 ]
Hoda, Syed [3 ]
Solomon, James [1 ]
机构：
[1] New York Presbyterian Weill Cornell Med, New York, NY USA
[2] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[3] Weill Cornell Med, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
186
引用
收藏
页码：S176 / S177
页数：2
相关论文
共 50 条
  • [1] Genomic and Transcriptomic Landscape of HER2-Low Breast Cancer
    Bansal, Rani
    McGrath, Julie
    Walker, Phil
    Bustos, Matias A.
    Rodriguez, Estelamari
    Sammons, Sarah L.
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret
    Hsu, Emily
    Lathrop, Kate I.
    Kaklamani, Virginia
    Oberley, Matthew
    Korn, W. Michael
    Graff, Stephanie L.
    CANCER RESEARCH, 2023, 83 (05)
  • [2] HER2-Low Breast Cancer: Pathological and Clinical Landscape
    Tarantino, Paolo
    Hamilton, Erika
    Tolaney, Sara M.
    Cortes, Javier
    Morganti, Stefania
    Ferraro, Emanuela
    Marra, Antonio
    Viale, Giulia
    Trapani, Dario
    Cardoso, Fatima
    Penault-Llorca, Frederique
    Viale, Giuseppe
    Andre, Fabrice
    Curigliano, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) : 1951 - +
  • [3] Genomic and transcriptomic landscape of HER2-low breast cancer
    Bansal, Rani
    Adeyelu, Tolulope
    Elliott, Andrew
    Walker, Phillip
    Bustos, Matias A.
    Rodriguez, Estelamari
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret E.
    Hsu, Emily
    Lathrop, Kate
    Kaklamani, Virginia
    Oberley, Matthew
    Sledge, George
    Sammons, Sarah L.
    Graff, Stephanie L.
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (02) : 323 - 330
  • [4] Mutational landscape of HER-2 low breast cancer
    Vosoughi, Elham
    Nafissi, Nellie
    Mahadevan, Aditya
    Lee, Seungshin
    Mehta, Rita S.
    Parajuli, Ritesh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] HER2-Low Breast Cancer: Current Landscape and Future Prospects
    Shirman, Yelena
    Lubovsky, Shlomit
    Shai, Ayelet
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 605 - 616
  • [6] Assessment of HER2-Low Status in HER2-Mutant Breast Carcinoma
    Yang, Ellen
    Pareja, Fresia
    Rana, Satshil
    Brannon, A.
    Vanderbilt, Chad
    Dikoglu, Esra
    Grabenstetter, Anne
    Wen, Hannah
    Brogi, Edi
    Ross, Dara
    LABORATORY INVESTIGATION, 2024, 104 (03) : S313 - S315
  • [7] The effect of fixation time on HER2-low status in breast carcinoma
    Nofech-Mozes, S.
    Lu, F.
    Slodkowska, E.
    Plotkin, A.
    Olkhov-Mitsel, E.
    VIRCHOWS ARCHIV, 2024, 485 : S4 - S4
  • [8] Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
    Zhang, Huina
    Peng, Yan
    CANCERS, 2023, 15 (01)
  • [9] HER2-low versus HER2-0 in Invasive Lobular Breast Carcinoma
    Fontes-Sousa, M.
    de Sousa, L.
    Ribeiro, L.
    Torres, S. Pinto
    Costa, D. Alpuim
    Pinto, C. Gama
    Mestre, L.
    Borralho, P.
    Raimundo, A.
    Negreiros, I.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S86 - S87
  • [10] Genomic landscape of circulating tumor DNA in HER2-low metastatic breast cancer
    Yi, Zongbi
    Feng, Kaixiang
    Lv, Dan
    Guan, Yanfang
    Shao, Youcheng
    Ma, Fei
    Xu, Binghe
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
12345